Clinical trial
Prediction Study or Response to Treatment With Anti-CGRP Monoclonal Antibodies in Migraine
NCT06459648 is registered in ClinicalTrials.gov with Fundación de Investigación Biomédica - Hospital Universitario de La Princesa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prediction Study or Response to Treatment With Anti-CGRP Monoclonal Antibodies in Migraine
- Lead sponsor
- Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- April 26, 2023
- Completion date
- December 31, 2026
- Enrollment
- 350 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
migraine